scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPLUNG.2001.281.5.L1058 |
P698 | PubMed publication ID | 11597896 |
P2093 | author name string | Black SM | |
Dettman RW | |||
Wedgwood S | |||
P2860 | cites work | Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade | Q22010217 |
Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells | Q28566071 | ||
The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
Requirement for generation of H2O2 for platelet-derived growth factor signal transduction | Q29615245 | ||
NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs | Q34574361 | ||
Hypercholesterolemia increases endothelial superoxide anion production | Q35610616 | ||
Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus | Q37364913 | ||
Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells | Q37679126 | ||
TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement | Q38472345 | ||
LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells | Q41010076 | ||
Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line | Q41098628 | ||
Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. | Q41988723 | ||
Effect of thiol modulators and Cu/Zn superoxide dismutase inhibition on nitrergic relaxations in the rat gastric fundus | Q42580425 | ||
Persistent fetal circulation: Newly recognized structural features | Q43692241 | ||
Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs | Q44271978 | ||
Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds | Q46469206 | ||
Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals | Q50791803 | ||
Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. | Q54157220 | ||
Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. | Q54358716 | ||
P433 | issue | 5 | |
P921 | main subject | reactive oxygen species | Q424361 |
P304 | page(s) | L1058-67 | |
P577 | publication date | 2001-11-01 | |
P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
P1476 | title | ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species | |
P478 | volume | 281 |
Q36342127 | A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway |
Q36764714 | Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. |
Q44193719 | Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow |
Q35186599 | Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia |
Q41986030 | Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model |
Q46812170 | Antioxidant mechanism of Rutin on hypoxia-induced pulmonary arterial cell proliferation |
Q37112033 | Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension |
Q43218002 | Carotid atherosclerosis in elderly hypertensive patients: potential role of endothelin and plasma antioxidant capacity. |
Q33661117 | Cell signaling by protein carbonylation and decarbonylation |
Q57126867 | Change of voltage-gated potassium channel 1.7 expressions in monocrotaline-induced pulmonary arterial hypertension rat model |
Q44299854 | Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat. |
Q38420382 | Conceptual approaches for treatment of phosgene inhalation-induced lung injury. |
Q34118521 | Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity |
Q38266683 | Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease. |
Q54212760 | Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells. |
Q35859312 | Cyclic stretch stimulates mitochondrial reactive oxygen species and Nox4 signaling in pulmonary artery smooth muscle cells. |
Q27005594 | DNA Damage and Pulmonary Hypertension |
Q37371678 | Diabetes alters the expression of partial vasoactivators in cerebral vascular disease susceptible regions of the diabetic rat. |
Q35019587 | ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus |
Q37416218 | Early determinants of pulmonary vascular remodeling in animal models of complex congenital heart disease |
Q35123675 | Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats |
Q36972740 | Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors |
Q46420872 | Endothelin Confers Protection against High Glucose-Induced Neurotoxicity via Alleviation of Oxidative Stress |
Q89848967 | Endothelin-1 Downregulates Sulfur Dioxide/Aspartate Aminotransferase Pathway via Reactive Oxygen Species to Promote the Proliferation and Migration of Vascular Smooth Muscle Cells |
Q44179779 | Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species |
Q34431049 | Endothelin-1 augments Na⁺/H⁺ exchange activity in murine pulmonary arterial smooth muscle cells via Rho kinase |
Q35048898 | Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1 |
Q33799522 | Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase |
Q42005361 | Endothelin-1 stimulates catalase activity through the PKCδ-mediated phosphorylation of serine 167. |
Q46368139 | Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups |
Q37890242 | Epigenetic regulation of pulmonary arterial hypertension |
Q43182905 | Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn |
Q33764751 | Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension |
Q38112029 | Hypoxic pulmonary hypertension of the newborn |
Q37281476 | IL-22 activates oxidant signaling in pulmonary vascular smooth muscle cells |
Q28550890 | Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats |
Q37322260 | Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn |
Q39663088 | Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn. |
Q28566423 | Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release |
Q36552310 | Inhibition of the renin angiotensin system: implications for the endothelium |
Q85561781 | Integrin β1 is required for dermal homeostasis |
Q35325870 | Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species |
Q36319989 | Iron chelation inhibits the development of pulmonary vascular remodeling |
Q34519078 | Mechanisms of NFATc3 activation by increased superoxide and reduced hydrogen peroxide in pulmonary arterial smooth muscle |
Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
Q35084278 | Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn |
Q39132107 | NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension |
Q38596162 | NADPH oxidases-do they play a role in TRPC regulation under hypoxia? |
Q37138896 | NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. |
Q33916946 | Nitric oxide alterations following acute ductal constriction in the fetal lamb: a role for superoxide |
Q36627420 | Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide |
Q36480016 | Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb |
Q33333142 | Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness |
Q28087462 | Pathogenesis of diabetic cerebral vascular disease complication |
Q30583630 | Pulmonary arterial hypertension: the clinical syndrome |
Q36859451 | Pulmonary hypertension associated with COPD. |
Q37535062 | Pulmonary hypertension complicating congenital heart disease |
Q57176722 | Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia |
Q37376997 | Reactive oxygen and nitrogen species in pulmonary hypertension |
Q36747034 | Reactive oxygen species and antioxidants in pulmonary hypertension |
Q37532988 | Reactive oxygen species in pulmonary vascular remodeling |
Q36877325 | Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia |
Q33689229 | Redox signaling, vascular function, and hypertension |
Q37676060 | Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation |
Q37801516 | Regulation of the Pulmonary Circulation in the Fetus and Newborn |
Q39700439 | Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors |
Q35087019 | Role of endothelin-1 in hypertension |
Q28078566 | Role of oxidized lipids in pulmonary arterial hypertension |
Q38172267 | Role of reactive oxygen species in neonatal pulmonary vascular disease |
Q26747812 | Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension |
Q33588200 | Size-dependent Effects of Gold Nanoparticles on Osteogenic Differentiation of Human Periodontal Ligament Progenitor Cells. |
Q46186037 | Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca(2+) sensitization. |
Q38165146 | Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases |
Q40013771 | The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. |
Q27009064 | The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis |
Q55394065 | The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series). |
Q42975224 | The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. |
Q33970205 | Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis |
Search more.